×

MediciNova Receives a Notice of European Patent Allowance for Treating Progressive Multiple Sclerosis

CONTACT: Mark Johnson Investor Relations MediciNova, Inc. (858) 373-1500 info@medicinova.com MEDIA CONTACT: Stephanie Ashe Continuum Health Communications 650-245-0425 sashe@continuumhealthcom.com

MediciNova, Inc.